-+ 0.00%
-+ 0.00%
-+ 0.00%

Biovica International Secures SEK2 Million Testing Services Deal for Clinical Trial

MT Newswires·07/14/2026 05:10:39
Listen to the news
05:10 AM EDT, 07/14/2026 (MT Newswires) -- Biovica International (BIOVIC-B.ST) secured a contract worth 1.7 million kronor to provide its DiviTum TKa testing services to an unnamed pharmaceutical company. The Swedish biotechnology group said Tuesday that its services will be used for an up to four-year clinical breast cancer trial that will evaluate a CDK inhibitor with an endocrine treatment. The company noted that it will start testing in October at its CLIA-certified laboratory in California, US.